What is the appropriate ampicillin‑sulbactam dosing regimen for a patient on intermittent hemodialysis?

Ampicillin-Sulbactam Dosing in Hemodialysis Patients

For patients on intermittent hemodialysis, administer ampicillin-sulbactam 2 g/1 g (ampicillin/sulbactam) intravenously every 12 hours, with one dose given immediately after each dialysis session. 1

Pharmacokinetic Rationale

Both ampicillin and sulbactam are highly dialyzable, with approximately 71% of ampicillin and 78% of sulbactam eliminated by intact kidneys 1. During hemodialysis:

• Dialyzer clearance averages 80.1 ml/min for ampicillin and 83.3 ml/min for sulbactam when using high-flux dialyzers 1
• Elimination half-life during dialysis is dramatically shortened to 2.8 hours for ampicillin and 3.5 hours for sulbactam, compared to 17.4 hours off dialysis 1, 2
• Post-dialysis dosing is critical because significant drug removal occurs during each session 1

Standard Dosing Regimen

The recommended dose is ampicillin 2 g/sulbactam 1 g IV every 12 hours, with one dose administered after each dialysis session. 1 This regimen:

• Maintains adequate free ampicillin concentrations above 12 μg/mL between doses 3
• Prevents drug accumulation while ensuring therapeutic levels 1
• Provides satisfactory inhibitory and bactericidal activity for most susceptible organisms 4

Critical Timing Considerations

Always administer one dose immediately after hemodialysis to compensate for drug removal during the dialysis session 5, 1. The dosing schedule should be:

• On dialysis days: Give 2 g/1 g immediately post-dialysis, then 12 hours later
• Off dialysis days: Continue 2 g/1 g every 12 hours 1

Extended Dialysis Modifications

For patients undergoing extended daily dialysis (EDD) with longer treatment times (8 hours) and high-flux membranes:

• Use at least 2 g/1 g twice daily to avoid underdosing 1, 2
• The elimination half-life can be as short as 1.5 hours during EDD, necessitating higher or more frequent dosing 2
• Standard outpatient hemodialysis dosing (2 g/1 g once daily) results in significant underdosing in EDD patients 2

Severe Infections and Resistant Organisms

For severe infections or multidrug-resistant organisms (particularly Acinetobacter baumannii with MIC ≤4 mg/L):

• Consider increasing to 3 g/1.5 g every 12 hours post-dialysis 6, 5
• Use 4-hour extended infusions to optimize pharmacokinetic/pharmacodynamic properties 6, 7
• This higher-dose regimen maintains therapeutic concentrations for organisms with MIC up to 8 μg/mL 7

Common Pitfalls to Avoid

• Never use once-daily dosing in hemodialysis patients—this results in subtherapeutic levels and treatment failure 2
• Do not skip the post-dialysis dose—dialysis removes substantial drug, and omitting this dose creates a prolonged period of inadequate coverage 5, 1
• Avoid underdosing in extended dialysis—patients on EDD require at least twice-daily dosing, not the reduced frequency used in conventional intermittent hemodialysis 1, 2
• Monitor for accumulation in anuric patients—while twice-daily dosing prevents accumulation, verify renal function status and adjust if residual function exists 1

Alternative for Peritoneal Dialysis

For patients on continuous ambulatory peritoneal dialysis (CAPD), the dosing differs:

• Administer 2 g/1 g every 12 hours (intravenous or intraperitoneal) 4
• Intraperitoneal administration achieves 60-68% bioavailability with peak serum concentrations of 48 μg/mL (ampicillin) and 27.8 μg/mL (sulbactam) 4
• The 12-hour interval maintains adequate dialysate concentrations for most organisms 4